1 – 13 of 13
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Estrogen receptors and inflammation in colorectal cancer. Role in prognosis and therapeutic opportunities. (
- 2016
- Estrogen Receptor Beta Selective Agonists as Agents to Treat Chemotherapeutic-Induced Neuropathic Pain (
- 2014
- Deficiency of ER beta and prostate tumorigenesis in FGF8b transgenic mice (
- Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study (
- 2008
- Haplotypes of the estrogen receptor beta gene and breast cancer risk (
- Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study (
- Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist (
- Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist (
- 2007
- Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma (
- 2005
- Estrogen receptor alpha and beta in breast cancer - gene expression profiles and clinical implications (
- 2001
- Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat (
- 2000
- Estrogen receptor content in malignant breast tumors in men--a review (
- Increased magnitude of relaxation to oestrogen in aorta from oestrogen receptor beta knock-out mice (